Item 5.07. Submission of Matters to a Vote of Security Holders.

At the annual meeting (the "Annual Meeting") of stockholders of Zivo Bioscience, Inc. (the "Company") on October 12, 2021, stockholders (i) elected five directors to the Company's Board of Directors (the "Board") to serve a one-year term until the 2022 annual meeting of stockholders, (ii) ratified the appointment of Wolinetz, Lafazan & Company, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021, (iii) approved the Company's the adoption of the Zivo Bioscience, Inc. 2021 Equity Incentive Plan, and (iv) approved (on an advisory basis) the compensation of the Company's named executive officers. Proposals are described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on September 13, 2021, as supplemented on September 22, 2021.

A total of 5,624,833 shares of the Company's common stock were present at the meeting in person or by proxy, which represents approximately 60.6% of the shares of common stock outstanding as of the record date for the Annual Meeting.

The results of the voting are shown below:

Proposal 1-Election of Directors





                                                                 Broker
Nominee                    Votes For       Votes Withheld       Non-Votes
Andrew A. Dahl              3,628,107              160,285       1,836,441
Christopher D. Maggiore     3,735,720               52,672       1,836,441
Nola E. Masterson           3,679,971              108,421       1,836,441
John B. Payne               3,713,558               74,834       1,836,441
Alison A. Cornell           3,762,647               25,745       1,836,441




Proposal 2-Ratification of Appointment of Independent Registered Public
Accounting Firm



 Votes For       Votes Against       Votes Abstain
  5,526,523              17,457              80,853




Proposal 3-Approval of the adoption of the Zivo Bioscience, Inc. 2021 Equity
Incentive Plan



 Votes For       Votes Against       Votes Abstain
  3,404,827             217,934             165,631

Proposal 4-Approval (on an advisory basis) of the compensation of the Company's named executive officers





 Votes For       Votes Against       Votes Abstain
  3,416,788             220,711             150,893





2

© Edgar Online, source Glimpses